DOCS insider sale of 2,000 shares at $70.01 and option exercise
Rhea-AI Filing Summary
Doximity insiders reported coordinated transactions on 10/01/2025. Reporting person Kira Wampler, a director, sold 2,000 shares of Class A common stock at $70.01 and concurrently acquired 2,000 shares through conversion/exercise activity tied to outstanding Class B shares and stock options. After these transactions the reporting person beneficially owned 19,839 shares of Class A common stock and 466,700 shares of Class B common stock (equivalent to Class A on conversion). The sale executed under a pre-existing Rule 10b5-1 plan adopted on 11/12/2024, and the stock option exercised carries a $1.54 exercise price with a 06/09/2030 expiration for the vested portion.
Positive
- Sale executed under a Rule 10b5-1 plan, indicating pre-planned, non-discretionary disposition
- Options vested and exercised at a low strike of $1.54, demonstrating value capture from long-dated grants
Negative
- Insider sold 2,000 shares at $70.01, reducing direct Class A holdings from reported levels
- Beneficial ownership of Class A shares decreased to 19,839 following the sale
Insights
Insider used a Rule 10b5-1 plan for an automatic sale and exercised vested options.
The Form 4 shows a Rule 10b5-1 plan triggered the sale of 2,000 Class A shares at $70.01, indicating pre-planned disposition rather than an ad-hoc sale.
The reporting person also exercised or converted instruments that netted 2,000 shares, reflecting routine option vesting and conversion mechanics tied to Class B shares.
Vesting schedule and option economics are explicit: $1.54 strike, vested monthly since 2020.
The exercised stock option has a $1.54 exercise price and vested in monthly installments after 3/27/2020; the option grant date was 6/10/2020. The exercised shares add 2,000 Class A-equivalent shares to beneficial ownership.